Journal of Developing Drugs
Open Access
ISSN: 2329-6631
ISSN: 2329-6631
Chi-Chiu Mok
Department of Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong, SAR China
Mok is the Chief of Rheumatology in the Department of Medicine, Tuen Mun Hospital and Center for Assessment and Treatment of Rheumatic Diseases at Pok Oi Hospital, Hong Kong. He is also the President of the Hong Kong Society of Rheumatology. Dr. Mok is the principal investigator of a number of clinical trials of novel biological agents in systemic lupus erythematosus, rheumatoid arthritis and glucocorticoid-induced osteoporosis. In addition, Dr. Mok is the core editorial member of a number of international journals in Rheumatology and is the adhoc reviewer of more than 50 Rheumatology and General Medical Journals. He has reviewed more than 279 clinical papers and 6 grant applications.
Systemic lupus erythematosus in particular lupus nephritis, Rheumatology, Nephrolog, Diagnosis and management of various rheumatic diseases.